Altis Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 2018 in Tiruchirappalli, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85300TN2018PTC125647. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.13 M.
Employing 6 professional, Its leadership includes Ramasamy Ahila (Director), Chandrasekar Amutha (Director), Vasudevan Stella Grace Mary (Director). Past directors included Ramasamy Ahila. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No C-135/A, 3Rd Floor,, 5Th Cross East, Thillai Nagar, Tiruchirappalli, Tamil Nadu, 620018.
U85300TN2018PTC125647
125647
05 November 2018
₹1.00 Cr
₹7.13 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Altis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramasamy Ahila | Director | 12 Oct 2020 | Current |
| Chandrasekar Amutha | Director | 23 Nov 2018 | Current |
| Vasudevan Stella Grace Mary | Director | 23 Nov 2018 | Current |
| Kavitha Ananth | Director | 05 Nov 2018 | Current |
| Vignesh Thiyagarajan | Managing Director | 05 Nov 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Altis Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19121.48% increase. The company also saw a substantial improvement in profitability, with a 298.91% increase in profit. The company's net worth moved up by a moderate rise of 8.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Altis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Altis Pharmaceuticals has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Altis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Altis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Altis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
The activity Ramasamy Ahila was appointed as a Director was appointed as a Director on 12 Oct 2020 & has been associated with this company since 5 years 2 months . was completed.
The activity Chandrasekar Amutha was appointed as a Director was appointed as a Director on 23 Nov 2018 & has been associated with this company since 7 years 26 days . was completed.
Vasudevan Stella Grace Mary was appointed as a Director was appointed as a Director on 23 Nov 2018 & has been associated with this company since 7 years 26 days . was recorded as a recent event.
The activity Kavitha Ananth was appointed as a Director was appointed as a Director on 05 Nov 2018 & has been associated with this company since 7 years 1 month . was completed.
The CIN of Altis Pharmaceuticals Private Limited is U85300TN2018PTC125647.
Altis Pharmaceuticals Private Limited is headquartered at No C-135/A, 3Rd Floor,, 5Th Cross East, Thillai Nagar, Tiruchirappalli, Tamil Nadu, 620018.
Altis Pharmaceuticals Private Limited was incorporated on 05 November 2018.
The current directors of Altis Pharmaceuticals Private Limited are
The primary industry of Altis Pharmaceuticals Private Limited is Manufacturing.
Altis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Altis Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.13 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX